Meeting
2024 ASCO Annual Meeting
Association of napsin A-specific T cell clonotypes with durable clinical benefit to immunotherapy in patients with metastatic NSCLC.
Authors
Natalie J. Miller
University of Washington, Seattle, WA
Natalie J. Miller , Christina S Baik , Joel W. Neal , A. McGarry Houghton , Viswam S. Nair , Rafael Santana-Davila , Sylvia Lee , Keith D. Eaton , Renato G. Martins , Heather A. Wakelee , Sukhmani Kaur Padda , Shin-Heng Chiou , Diane Tseng
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Biologic Correlates
Citation
J Clin Oncol 42, 2024 (suppl 16; abstr 8527)
DOI
10.1200/JCO.2024.42.16_suppl.8527
Abstract #
8527
Poster Bd #
391
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Characterization of anti-cancer immune response associated with immune-related adverse events in patients with kidney cancer.
First Author: Taigo Kato
Poster
2019 ASCO-SITC Clinical Immuno-Oncology Symposium
Targeted sequencing of plasma cell-free DNA to predict response to PD1 inhibitors in advanced non-small cell lung cancer.
First Author: Nicolas Guibert
Poster
2024 ASCO Breakthrough
Dietary pattern and the corresponding gut microbiome in response to immunotherapy in Thai patients with advanced non-small cell lung cancer (NSCLC).
First Author: Piyada Sitthideatphaiboon
Poster
2024 ASCO Annual Meeting
PD-L1 expression in pulmonary sarcomatoid carcinoma and response to immunotherapy.
First Author: Lingzhi Hong